Transforming growth factor-β1 inhibits type I inositol 1,4,5- trisphosphate receptor expression and enhances its phosphorylation in mesangial cells

Kumar Sharma, Lewei Wang, Yanqing Zhu, Shaila Bokkala, Suresh K. Joseph

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

A potentially important cross-talk characteristic of transforming growth factor-β (TGF-β) is to inhibit platelet-derived growth factor-induced intracellular calcium rise (Baffy, G., Sharma, K., Shi, W., Ziyadeh, F. N., and Williamson, J. R. (1995) Biochem. Biophys. Res. Commun. 210, 378-383) in murine mesangial cells. The present study examined the possible basis for this effect by evaluating the regulation of the type I inositol 1,4,5- trisphosphate receptor (IP3R) by TGF-β. TGF-β1 down-regulates IP3R protein expression by >90% with maximal and half-maximal effects after 8 and 2 h, respectively. TGF-β1 also decreased IP3R mRNA expression by 59% after 1 h. Phosphorylation of the IP3R was also demonstrated as early as 15 min after TGF-β1 exposure. Back phosphorylation assays of IP3R from TGF-β1- treated mesangial cells with protein kinase A (PKA), indicated that TGF-β1- induced phosphorylation of the IP3R occurs at similar sites as for PKA. In vitro kinase assays using the known IP3R peptide substrates for PKA, RPS- GRRESLTSFGNP and ARRDSVLAAS, demonstrated that TGF-β1 induces phosphorylation of both peptides (158 and 123% of control values, respectively). TGF-β1-induced phosphorylation was prevented by the addition of the PKA inhibitor peptide in the in vitro kinase assay. It is proposed that TGF-β-mediated effects on the IP3R may be an important characteristic of its ability to modulate the response of cells to factors that employ IP3R-mediated calcium release.

Original languageEnglish (US)
Pages (from-to)14617-14623
Number of pages7
JournalJournal of Biological Chemistry
Volume272
Issue number23
DOIs
StatePublished - Jun 6 1997
Externally publishedYes

Fingerprint

Inositol 1,4,5-Trisphosphate Receptors
Phosphorylation
Mesangial Cells
Transforming Growth Factors
Cyclic AMP-Dependent Protein Kinases
Assays
Peptides
Phosphotransferases
Calcium
Platelet-Derived Growth Factor
Down-Regulation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Transforming growth factor-β1 inhibits type I inositol 1,4,5- trisphosphate receptor expression and enhances its phosphorylation in mesangial cells. / Sharma, Kumar; Wang, Lewei; Zhu, Yanqing; Bokkala, Shaila; Joseph, Suresh K.

In: Journal of Biological Chemistry, Vol. 272, No. 23, 06.06.1997, p. 14617-14623.

Research output: Contribution to journalArticle

@article{03d3414be2284f979b8f906ca623dc7c,
title = "Transforming growth factor-β1 inhibits type I inositol 1,4,5- trisphosphate receptor expression and enhances its phosphorylation in mesangial cells",
abstract = "A potentially important cross-talk characteristic of transforming growth factor-β (TGF-β) is to inhibit platelet-derived growth factor-induced intracellular calcium rise (Baffy, G., Sharma, K., Shi, W., Ziyadeh, F. N., and Williamson, J. R. (1995) Biochem. Biophys. Res. Commun. 210, 378-383) in murine mesangial cells. The present study examined the possible basis for this effect by evaluating the regulation of the type I inositol 1,4,5- trisphosphate receptor (IP3R) by TGF-β. TGF-β1 down-regulates IP3R protein expression by >90{\%} with maximal and half-maximal effects after 8 and 2 h, respectively. TGF-β1 also decreased IP3R mRNA expression by 59{\%} after 1 h. Phosphorylation of the IP3R was also demonstrated as early as 15 min after TGF-β1 exposure. Back phosphorylation assays of IP3R from TGF-β1- treated mesangial cells with protein kinase A (PKA), indicated that TGF-β1- induced phosphorylation of the IP3R occurs at similar sites as for PKA. In vitro kinase assays using the known IP3R peptide substrates for PKA, RPS- GRRESLTSFGNP and ARRDSVLAAS, demonstrated that TGF-β1 induces phosphorylation of both peptides (158 and 123{\%} of control values, respectively). TGF-β1-induced phosphorylation was prevented by the addition of the PKA inhibitor peptide in the in vitro kinase assay. It is proposed that TGF-β-mediated effects on the IP3R may be an important characteristic of its ability to modulate the response of cells to factors that employ IP3R-mediated calcium release.",
author = "Kumar Sharma and Lewei Wang and Yanqing Zhu and Shaila Bokkala and Joseph, {Suresh K.}",
year = "1997",
month = "6",
day = "6",
doi = "10.1074/jbc.272.23.14617",
language = "English (US)",
volume = "272",
pages = "14617--14623",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "23",

}

TY - JOUR

T1 - Transforming growth factor-β1 inhibits type I inositol 1,4,5- trisphosphate receptor expression and enhances its phosphorylation in mesangial cells

AU - Sharma, Kumar

AU - Wang, Lewei

AU - Zhu, Yanqing

AU - Bokkala, Shaila

AU - Joseph, Suresh K.

PY - 1997/6/6

Y1 - 1997/6/6

N2 - A potentially important cross-talk characteristic of transforming growth factor-β (TGF-β) is to inhibit platelet-derived growth factor-induced intracellular calcium rise (Baffy, G., Sharma, K., Shi, W., Ziyadeh, F. N., and Williamson, J. R. (1995) Biochem. Biophys. Res. Commun. 210, 378-383) in murine mesangial cells. The present study examined the possible basis for this effect by evaluating the regulation of the type I inositol 1,4,5- trisphosphate receptor (IP3R) by TGF-β. TGF-β1 down-regulates IP3R protein expression by >90% with maximal and half-maximal effects after 8 and 2 h, respectively. TGF-β1 also decreased IP3R mRNA expression by 59% after 1 h. Phosphorylation of the IP3R was also demonstrated as early as 15 min after TGF-β1 exposure. Back phosphorylation assays of IP3R from TGF-β1- treated mesangial cells with protein kinase A (PKA), indicated that TGF-β1- induced phosphorylation of the IP3R occurs at similar sites as for PKA. In vitro kinase assays using the known IP3R peptide substrates for PKA, RPS- GRRESLTSFGNP and ARRDSVLAAS, demonstrated that TGF-β1 induces phosphorylation of both peptides (158 and 123% of control values, respectively). TGF-β1-induced phosphorylation was prevented by the addition of the PKA inhibitor peptide in the in vitro kinase assay. It is proposed that TGF-β-mediated effects on the IP3R may be an important characteristic of its ability to modulate the response of cells to factors that employ IP3R-mediated calcium release.

AB - A potentially important cross-talk characteristic of transforming growth factor-β (TGF-β) is to inhibit platelet-derived growth factor-induced intracellular calcium rise (Baffy, G., Sharma, K., Shi, W., Ziyadeh, F. N., and Williamson, J. R. (1995) Biochem. Biophys. Res. Commun. 210, 378-383) in murine mesangial cells. The present study examined the possible basis for this effect by evaluating the regulation of the type I inositol 1,4,5- trisphosphate receptor (IP3R) by TGF-β. TGF-β1 down-regulates IP3R protein expression by >90% with maximal and half-maximal effects after 8 and 2 h, respectively. TGF-β1 also decreased IP3R mRNA expression by 59% after 1 h. Phosphorylation of the IP3R was also demonstrated as early as 15 min after TGF-β1 exposure. Back phosphorylation assays of IP3R from TGF-β1- treated mesangial cells with protein kinase A (PKA), indicated that TGF-β1- induced phosphorylation of the IP3R occurs at similar sites as for PKA. In vitro kinase assays using the known IP3R peptide substrates for PKA, RPS- GRRESLTSFGNP and ARRDSVLAAS, demonstrated that TGF-β1 induces phosphorylation of both peptides (158 and 123% of control values, respectively). TGF-β1-induced phosphorylation was prevented by the addition of the PKA inhibitor peptide in the in vitro kinase assay. It is proposed that TGF-β-mediated effects on the IP3R may be an important characteristic of its ability to modulate the response of cells to factors that employ IP3R-mediated calcium release.

UR - http://www.scopus.com/inward/record.url?scp=0030915445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030915445&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.23.14617

DO - 10.1074/jbc.272.23.14617

M3 - Article

VL - 272

SP - 14617

EP - 14623

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 23

ER -